000 | 01709 a2200517 4500 | ||
---|---|---|---|
005 | 20250517120714.0 | ||
264 | 0 | _c20170728 | |
008 | 201707s 0 0 eng d | ||
022 | _a1559-0100 | ||
024 | 7 |
_a10.1007/s12020-016-1120-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVroonen, Laurent | |
245 | 0 | 0 |
_aProspective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia. _h[electronic resource] |
260 |
_bEndocrine _c01 2017 |
||
300 |
_a239-245 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aCabergoline |
650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
650 | 0 | 4 | _aEchocardiography |
650 | 0 | 4 |
_aErgolines _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Valve Diseases _xdiagnostic imaging |
650 | 0 | 4 |
_aHeart Valves _xdiagnostic imaging |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperprolactinemia _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPituitary Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aProlactinoma _xcomplications |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aLancellotti, Patrizio | |
700 | 1 | _aGarcia, Monica Tomé | |
700 | 1 | _aDulgheru, Raluca | |
700 | 1 | _aRubio-Almanza, Matilde | |
700 | 1 | _aMaiga, Ibrahima | |
700 | 1 | _aMagne, Julien | |
700 | 1 | _aPetrossians, Patrick | |
700 | 1 | _aAuriemma, Renata | |
700 | 1 | _aDaly, Adrian F | |
700 | 1 | _aBeckers, Albert | |
773 | 0 |
_tEndocrine _gvol. 55 _gno. 1 _gp. 239-245 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12020-016-1120-5 _zAvailable from publisher's website |
999 |
_c26489372 _d26489372 |